3//SEC Filing
ACORN BIOVENTURES 2, L.P. 3
Accession 0000950170-25-078004
CIK 0001637715other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 7:44 PM ET
Size
6.3 KB
Accession
0000950170-25-078004
Insider Transaction Report
Form 3
Acorn Capital Advisors GP 2, LLC
10% Owner
Holdings
- 1,129,730
Common Stock
ACORN BIOVENTURES 2, L.P.
10% Owner
Holdings
- 1,129,730
Common Stock
Footnotes (1)
- [F1]Shares held directly by Acorn Bioventures 2, L.P. ("Acorn 2"). Acorn Capital Advisors GP 2, LLC ("Acorn GP 2") is the general partner of Acorn 2. Anders Hove is the manager of Acorn GP 2. Each of Acorn GP 2 and Mr. Hove disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
OnKure Therapeutics, Inc.
CIK 0001637715
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001876405
Filing Metadata
- Form type
- 3
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 7:44 PM ET
- Size
- 6.3 KB